×

Johnson & Johnson

NYS: JNJ

GO
/marketstate/country/us

Market open

JNJ
/zigman2/quotes/201724570/composite

$

130.62

Change

+0.21 +0.16%

Volume

Volume 954,858

Sep 19, 2019, 11:05 a.m.

Real time quotes

/zigman2/quotes/201724570/composite

Previous close

$ 130.41

$ 130.62

Change

+0.21 +0.16%

Day low

Day high

$129.36

$131.19

Open
Open: 129.63

52 week low

52 week high

$121.00

$148.99

Open

Market cap

$344.17B

Average volume

7.48M

P/E ratio

21.70

Rev. per Employee

$603,509

EPS

6.03

Dividend

0.95

Div yield

2.90%

Ex dividend date

8/26/19

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/jnj

MarketWatch News on JNJ

  1. Johnson & Johnson Stock Is Going to Rise Despite Opioid Lawsuits, Analyst Says

    10:02 a.m. Today

    - Josh Nathan-Kazis

  2. Worried about the stock market? Here are easy ways to cut risk

    10:52 a.m. Sept. 16, 2019

    - Philip van Doorn

  3. Dow flat despite gains for Dow Inc., Boeing stocks

    3:55 p.m. Sept. 10, 2019

    - Automated Insights

  4. Mallinckrodt Bankruptcy Fear May Be Premature

    9:38 a.m. Sept. 6, 2019

    - Josh Nathan-Kazis

  5. How Biotech Is Targeting RNA to Cure Diseases

    8:01 a.m. Sept. 3, 2019

    - Josh Nathan-Kazis

  6. How the Johnson & Johnson Ruling Could Affect the Opioid Cases

    4:09 p.m. Aug. 30, 2019

    - Josh Nathan-Kazis

  7. Allergan Settles to Get Out of First Big Opioid Trial

    10:03 a.m. Aug. 30, 2019

    - Josh Nathan-Kazis

  8. Microsoft, Visa share losses contribute to Dow's 65-point fall

    9:45 a.m. Aug. 28, 2019

    - Automated Insights

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/jnj

Other News on JNJ

  1. FDA Warns About Safety of Breast Implant: 3 Stocks at Risk

    9:31 a.m. Today

    - Zacks.com

  2. DGI For The DIY: Q2 2019 Dividend Portfolio Update

    12:23 a.m. Today

    - Seeking Alpha

  3. Axsome Shares Flirt With Record High: How Much Upside Is Left?

    1:08 p.m. Sept. 18, 2019

    - benzinga.com

  4. FDA OKs Janssen Pharma's Erleada for mCSPC

    6:44 a.m. Sept. 18, 2019

    - Seeking Alpha

  5. JNJ Stock Is Undervalued, but Not Compelling Given These Headwinds

    6:40 a.m. Sept. 18, 2019

    - InvestorPlace.com

  6. Should You Buy Vegan Stocks & ETF?

    3:52 p.m. Sept. 17, 2019

    - Zacks.com

  7. Novartis Announces New Data on Spondylitis Drug Cosentyx

    11:05 a.m. Sept. 17, 2019

    - Zacks.com

  8. Karyopharm Signs $150M Royalty Agreement to Support Xpovio

    10:39 a.m. Sept. 17, 2019

    - Zacks.com

  9. Checking In On Our Dividend Growth Portfolios In 2019

    9:47 a.m. Sept. 17, 2019

    - Seeking Alpha

  10. 5 Things That Can Drive Powerful Stock Movements

    9:24 p.m. Sept. 16, 2019

    - Seeking Alpha

  11. Opioid Relief Rally Is Likely to Stall

    4:40 p.m. Sept. 16, 2019

    - Charley Grant

  12. ADC Therapeutics Begins U.S. IPO Process

    12:48 p.m. Sept. 16, 2019

    - Seeking Alpha

  13. AstraZeneca's Farxiga Gets Fast Track Tag for Heart Failure

    10:43 a.m. Sept. 16, 2019

    - Zacks.com

  14. Wall Street Breakfast: Oil Surges After Saudi Output Disruption

    7:00 a.m. Sept. 16, 2019

    - Seeking Alpha

  15. Loading more headlines...
/news/pressrelease/company/us/jnj

Press Releases on JNJ

  1. Coronary Stents Market Report: Industry Outlook By Drivers, Restraints And 2017-2023

    53 min ago

    - AmericaNewsHour

  2. Transdermal Drug Delivery Market: Industry Outlook By Drivers, Restraints And 2018-2024

    9:22 a.m. Today

    - AmericaNewsHour

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.